Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 5Breast 2Head & Neck 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Melanoma 241Carcinoma, Non-Small-Cell Lung 56Carcinoma, Renal Cell 40Skin Neoplasms 39Uveal Melanoma 31Squamous Cell Carcinoma of Head and Neck 30Neoplasms 30Colorectal Neoplasms 27Sarcoma 25Neoplasm Metastasis 25Carcinoma, Merkel Cell 24Ovarian Neoplasms 23Lung Neoplasms 22Stomach Neoplasms 21Carcinoma, Basal Cell 21Breast Neoplasms 20Head and Neck Neoplasms 18Esophageal Neoplasms 16Uterine Cervical Neoplasms 15Pancreatic Neoplasms 15Carcinoma, Hepatocellular 15Lymphoma, T-Cell, Cutaneous 14Urinary Bladder Neoplasms 13Triple Negative Breast Neoplasms 13Prostatic Neoplasms 13Carcinoma, Transitional Cell 13Brain Neoplasms 13Thyroid Neoplasms 11Small Cell Lung Carcinoma 10Mycosis Fungoides 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Cognitive Dysfunction × Dermatologic × Clear all
NCT04565769 2024-12-06

Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors

Aarhus University Hospital

Active not recruiting
100 enrolled
Dermatologic

Anxiety Disorders, Depression, Fatigue, Inflammation, Melanoma, Illness Behavior, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡